
ARQT vs ERAS
$ARQT vs $ERAS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ARQT vs ERAS: the quick read
- ·ERAS is the larger company by market cap ($4.76B vs $4.01B).
- ·ARQT has been more active on our scanner (162 vs 158 alerts in 30 days).
- ·ARQT has the smaller float (107.1M vs 303.9M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 162 and 158 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 19% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: ARQT is outperforming the other by roughly 9.7 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ARQT and ERAS on TheDesperateTrader.
- Is ARQT or ERAS the better stock?
- "Better" depends on your goal, and these two are not alike. ERAS is the larger company by market cap ($4.76B vs $4.01B). ARQT has been more active on our scanner (162 vs 158 alerts in 30 days). ARQT has the smaller float (107.1M vs 303.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ARQT and ERAS?
- The differences that matter: they are similar in size ($4.01B vs $4.76B); they trade at very different share prices ($32.12 vs $13.62); ARQT sits at 94% of its 52-week range against 52% for ERAS; our scanner flagged ARQT 162 times in the last 30 days against 158 for ERAS. Everything above is measured from the latest completed session and SEC filings.
- Which of ARQT and ERAS is more active right now?
- Right now ARQT is at about 1.9x its normal volume and ERAS is at about 0.8x, so ARQT is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ARQT or ERAS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ARQT and ERAS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.